Skip to main content

Fidelity — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

258
Companies
$29.6B
Total invested
$154.1M
Avg. check
57
Industries
Biotechnology 11Therapeutics 6Medical 5Health Care 4Financial Services 4Artificial Intelligence (AI) 4+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 258
Rapport Therapeutics
September 2025

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Biotechnology · Boston$250.0M Post-IPO Equity
SteelEye
September 2022

SteelEye develops a holistic compliance platform for record keeping, surveillance, and intelligent insights.

Analytics · London$21.0M Series B
Lightmatter
September 2025

Lightmatter develops photonic chips that enable data processing and communication using light instead of electricity.

AI Infrastructure · Mountain ViewSeries D
Veterinary Emergency Group
September 2021

Veterinary Emergency Group provides animals and their families with timely medical care for acute problems at times when pets need it.

Customer Service · White Plains$100.0M Series C
Skyhawk Therapeutics
September 2021

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

Biotechnology · Waltham$133.0M Venture - Series Unknown
AgBiome
September 2021

AgBiome discovers and develops innovative biological and trait products for crop protection.

Agriculture · Raleigh$116.0M Series D
StashAway
September 2022

StashAway is a wealth management platform that delivers personalized portfolio management to both retail and accredited investors.

Apps · Singapore$12.7M Series D
Codiak Biosciences
September 2022

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Biotechnology · San Francisco$20.0M Post-IPO Equity
Poseida Therapeutics
August 2023

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Biopharma · San Diego$25.0M Post-IPO Equity
ZILO
August 2026

ZILO is a fintech company that offers digital-first transfer agency software, digital assets, and wealth management solutions.

Artificial Intelligence (AI) · London$27.0M Corporate Round
FX HedgePool
August 2022

FX HedgePool is a peer-to-peer matching platform for institutional foreign exchange transactions.

Financial Services · New York$8.0M Series A
Laronde
August 2021

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Biotechnology · Cambridge$440.0M Series B
Moda Operandi
August 2024

Moda Operandi is an e-commerce platform connecting consumers with fashion designers.

E-Commerce · New York$10.0M Venture - Series Unknown
Study Plus
August 2022

Study Plus is an educational application developed to facilitate collaborative studying.

Apps · TokyoSeries D
QuantumScape
August 2023

QuantumScape develops solid-state lithium-metal batteries for electric vehicles and other energy storage applications.

Automotive · San Jose$300.0M Post-IPO Equity
T-knife
August 2021

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.

Biotechnology · Berlin$110.0M Series B
Epicrispr Biotechnologies
August 2026

Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation.

Biotechnology · South San Francisco$90.0M Series C
Allotera Therapeutics
July 2026

Allotera Therapeutics is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

Biotechnology · St Louis$35.0M Series C
Doma
July 2021

Doma is an insurtech platform that uses machine intelligence to remove friction from residential real estate transactions.

Artificial Intelligence (AI) · Miami$300.0M Post-IPO Equity
Deep Genomics
July 2021

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

Artificial Intelligence (AI) · Toronto$180.0M Series C
Aristea Therapeutics
July 2021

Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.

Biotechnology · San Diego$63.0M Series B
Kitchen United
July 2022

Kitchen United offers a turnkey solution for restaurant brands to profitably expand.

E-Commerce · Pasadena$100.0M Series C
Kry
July 2022

Kry helps patients to make active choices about their health in partnership with public and private healthcare professionals.

Consumer · Stockholm$160.0M Series D
Hyzon Motors
July 2024

Hyzon Motors is a global supplier of hydrogen fuel-cell powered commercial vehicles.

Automotive · Honeoye$4.5M Post-IPO Equity

Where Fidelity invests

Biotechnology11
Therapeutics6
Medical5
Health Care4
Financial Services4
Artificial Intelligence (AI)4

About Fidelity's portfolio

How many companies has Fidelity invested in?▸

Fidelity has invested in 258 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?▸

Fidelity's top investment sectors include Biotechnology, Therapeutics, Medical, Health Care, Financial Services. The firm invests across 57 different industry categories.

What is Fidelity's largest investment?▸

Among tracked funding rounds, Laronde received $440.0M in a Series B round. Fidelity's total known invested capital is $29.6B.

What is the average investment size for Fidelity?▸

Fidelity's average investment size is $154.1M across its portfolio of 258 companies.

What are Fidelity's most recent investments?▸

Recent Fidelity portfolio additions include Rapport Therapeutics, SteelEye, Lightmatter, Veterinary Emergency Group, Skyhawk Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 258 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →